METHOD: This is an experimental animal study. Image acquisition was conducted from 7/2008-11/2008 at the Advanced Photon Source of Argonne National Laboratory, where phase contrast images of mice and gerbil cochleae were captured using hard X-rays. Parameters included: photon energy 15-31.5keV, full width half maximum 630 m x 28 m, monochromatic flux 1013 photons/second, and beam size 1-2 mm2 at a distance 70 m from the source. The experimental image processing was conducted from 11/2008-2/2010. Qualitative analysis was compared for data sets from 12 cochleae, to determine processing parameters for optimal spatial resolution and anatomical identification. A rendered and segmented three-dimensional model of the decalcified mouse cochlea was created. Three-dimensional tomographic reconstructions were produced by the weighted back projection algorithm. The spatial resolution was determined by taking the lowest Full-Width Half-Maximum of the line spread function, measured using a sharp edge on Reissners membrane for the optimally oriented, decalcified mouse cochlea. RESULTS: Optimized PCCT reconstruction of a decalcified mouse cochlea revealed outer pillar cells, inner pillar cells, inner spiral sulcus, outer hair cells, tectorial membrane, basilar membrane pectinate zone, and Reissners membrane. The spatial resolution was determined to be 1.9 m. CONCLUSION: The results demonstrate the ability of PCCT to image cochlear structures at an unprecedented cellular level through the decalcified bony capsule. Future experiments will continue to refine imaging and reconstruction parameters to optimize imaging results.
OBJECTIVE:
The pinna is a cartilaginous structure that improves sound presentation to the middle ear mechanism. The relative contribution of individual pinna fossae and folds is yet to be fully established.
METHOD:
We modified an anatomically correct model ear into a variety of different shapes, filled and extended different fossae and recorded the effect on hearing gain. We compared an enlarged helix, an enlarged ear lobule, a filled conchal bowl, a filled scaphoid fossa and absent anti-helical fold, and a cupped ear with a normal ear. Readings were taken at 55, 65 and 80 dB SPL between frequencies of 200 and 8000Hz, through azimuths of zero to one hundred and eighty degrees. RESULTS: Our results suggest varying amounts of hearing gain and loss depending on the shape of the auricle. Gains and losses varied between frequencies of up to 7 dB SPL with maximum changes seen between zero and ninety degrees azimuth. CONCLUSION: The results of this study suggest that pinna shape and position may significantly affect hearing gain and changes to the pinna following procedures such as otoplasty may result in a significant hearing loss.
PKA/C in Bilirubin Potentiation of Synaptic Transmission
Haibo Shi, MD, PhD (presenter); Chunyan Li, MD; Shankai Yin, MD, PhD OBJECTIVE: Previous studies have suggested that bilirubin can potentiate GABA/glycinergic synaptic transmission, which might hint on bilirubin-induced dysfunction in some nucleus, but its molecular mechanism has not been clearly defined. The present study observed the effect of bilirubin on GABAergic/ glycinergic synaptic transmission in rat ventral cochlear nucleus (VCN) neurons, and the possible roles of protein kinase A (PKA) and C (PKC) in the effect. METHOD: VCN neurons acutely isolated from postnatal 10to 12-day-old rat were voltage-clamped under the whole-cell mode.
RESULTS:
The frequency of miniature inhibitory postsynaptic currents (mIPSCs) was by bilirubin without change in the amplitude. Both forskolin (PKA activator) and H-89 (PKA inhibitor) could also increase the mIPSCs frequency solely. Co-application of bilirubin further increased the frequency relative to H-89 condition, but did not to forskolin condition. Neither H-89, forskolin, nor their co-application of bilirubin could affect the amplitudes of mIPSCs and both GABA-activated (IGABA)and glycine-activated (Igly)currents, suggesting presynaptic locus of the facilitating actions. The mIPSCs frequency was enhanced by chelerythrine (PKC inhibitor), and further drastically increased in the co-application of bilirubin, with a decreased amplitude in mIPSC and IGABA and Igly. No alteration in mIPSCs was found in the presence of Phorbol 12, 13-diacetate (PKC activator). CONCLUSION: These data suggest that both PKA and PKC can modulate GABA and glycine release in P10-12 rat VCN neurons. Bilirubin facilitates the transmitter release via presynaptic activating PKA pathway, which might provide an insight in the molecular mechanism underlying bilirubin-induced hearing dysfunction.
Potential Safety Adjunct for Facial Nerve Monitoring
Robert Labadie, MD, PhD (presenter) OBJECTIVE: Intraoperative facial nerve monitoring is commonly employed in otologic surgery. However, a paucity of data exists regarding the accuracy, precision, and/or recording range of the monitoring during drilling. We sought to correlate the thickness of bone remaining over the facial nerve with facial nerve stimulation thresholds. This has clinical implications for the practitioner in understanding the power and the limitations of facial nerve monitoring.
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